middle.news
Chimeric Therapeutics to Consolidate Securities 100:1, Reshaping Capital Structure
8:36am on Thursday 19th of March, 2026 AEDT
•
Healthcare
Read Story
Chimeric Therapeutics to Consolidate Securities 100:1, Reshaping Capital Structure
8:36am on Thursday 19th of March, 2026 AEDT
Key Points
100:1 security consolidation ratio announced
Applies to ordinary shares, options, and performance rights
Shareholder approval required before proceeding
Deferred settlement trading to begin 22 April 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CHIMERIC THERAPEUTICS (ASX:CHM)
OPEN ARTICLE